Endo International (ENDP) Tops Q3 EPS by 12c, Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Endo Reports Third-Quarter 2018 Financial Results
November 8, 2018 7:01 AM ESTDUBLIN, Nov. 8, 2018 /PRNewswire/ --Â
Third-quarter 2018 revenues of $745 million compared to third-quarter 2017 revenues of $787 million Third-quarter 2018 XIAFLEX® franchise revenues increased 22 percent versus third-quarter 2017 to $64 million Third-quarter 2018 Sterile Injectables revenues increased 17 percent versus third-quarter 2017 to $237 million Company raises 2018 financial guidanceEndo International plc (NASDAQ: ENDP) today reported third-quarter 2018 financial results, including:
Revenues of $745 million, a decrease of 5 percent compared to third-quarter 2017 revenues of $787 million; revenues increased 4 percent compared to second-quarter 2018. Reported net loss from continuing operations of $146... More


